Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs

M. R. Gismondo, L. Drago, A. Lombardi, M. C. Fassina, B. Mombelli

Research output: Contribution to journalArticle

Abstract

Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal diseases. Gastroduodenal ulcer and Malt-lymphoma in particular, regress when patients are administered antimicrobial agents to eradicate infection. Somtimes eradication is not definitive and is difficult to check. The aim of our study was to test the antimicrobial activity of omeprazole on H. pylori in comparison with ampicillin and other anti-H2 drugs (ranitidine and famotidine), and to evaluate their interference with bacterial adhesion of H. pylori. We also compared results of the agar dilution antibacterial sensitivity test on H. pylori to those obtained using a bacteria adherence to cell monolayers model, to see if drug activity was different against adhered bacteria. We evaluated omeprazole and ampicillin MIC90s (minimum inhibitory concentrations) against 20 H. pylori isolates by traditional agar dilution method and by exposing previously adhered bacteria to an Hep-2 monolayer to different drug concentrations. The activity against bacteria adhered to cell lines was evaluated by counting viable adhered bacteria after 1, 6, 12 hours of contact with drug. Interference with adherence to Hep-2 cells was also tested. Omeprazole and arnpicillin MICs were comparable to other findings (omeprazole M1C90 was 12.5 μg/ml and ampicillin MIC90 was 0.016 μg/ml), while higher concentrations were necessary (4 x MIC90) against adhered bacteria. These findings suggest that MICs evaluated with traditional assays can have different predictivity than tests on adhered H. pylori.

Original languageEnglish
Pages (from-to)225-230
Number of pages6
JournalJournal of Chemotherapy
Volume10
Issue number3
Publication statusPublished - 1998

Fingerprint

Omeprazole
Helicobacter pylori
Bacteria
Ampicillin
Growth
Pharmaceutical Preparations
Agar
Famotidine
Bacterial Adhesion
Ranitidine
Microbial Sensitivity Tests
Gastritis
Anti-Infective Agents
Peptic Ulcer
Lymphoma
Cell Line
Infection

Keywords

  • Adhesion
  • Ampicillin
  • Antibacterial activity
  • Antisecretory drug
  • Gastritis
  • Helicobacter pylori
  • Omeprazole
  • Ulcer

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)

Cite this

Gismondo, M. R., Drago, L., Lombardi, A., Fassina, M. C., & Mombelli, B. (1998). Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs. Journal of Chemotherapy, 10(3), 225-230.

Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs. / Gismondo, M. R.; Drago, L.; Lombardi, A.; Fassina, M. C.; Mombelli, B.

In: Journal of Chemotherapy, Vol. 10, No. 3, 1998, p. 225-230.

Research output: Contribution to journalArticle

Gismondo, MR, Drago, L, Lombardi, A, Fassina, MC & Mombelli, B 1998, 'Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs', Journal of Chemotherapy, vol. 10, no. 3, pp. 225-230.
Gismondo, M. R. ; Drago, L. ; Lombardi, A. ; Fassina, M. C. ; Mombelli, B. / Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs. In: Journal of Chemotherapy. 1998 ; Vol. 10, No. 3. pp. 225-230.
@article{99aaed82a43542769d7ccab7c38b01ee,
title = "Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs",
abstract = "Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal diseases. Gastroduodenal ulcer and Malt-lymphoma in particular, regress when patients are administered antimicrobial agents to eradicate infection. Somtimes eradication is not definitive and is difficult to check. The aim of our study was to test the antimicrobial activity of omeprazole on H. pylori in comparison with ampicillin and other anti-H2 drugs (ranitidine and famotidine), and to evaluate their interference with bacterial adhesion of H. pylori. We also compared results of the agar dilution antibacterial sensitivity test on H. pylori to those obtained using a bacteria adherence to cell monolayers model, to see if drug activity was different against adhered bacteria. We evaluated omeprazole and ampicillin MIC90s (minimum inhibitory concentrations) against 20 H. pylori isolates by traditional agar dilution method and by exposing previously adhered bacteria to an Hep-2 monolayer to different drug concentrations. The activity against bacteria adhered to cell lines was evaluated by counting viable adhered bacteria after 1, 6, 12 hours of contact with drug. Interference with adherence to Hep-2 cells was also tested. Omeprazole and arnpicillin MICs were comparable to other findings (omeprazole M1C90 was 12.5 μg/ml and ampicillin MIC90 was 0.016 μg/ml), while higher concentrations were necessary (4 x MIC90) against adhered bacteria. These findings suggest that MICs evaluated with traditional assays can have different predictivity than tests on adhered H. pylori.",
keywords = "Adhesion, Ampicillin, Antibacterial activity, Antisecretory drug, Gastritis, Helicobacter pylori, Omeprazole, Ulcer",
author = "Gismondo, {M. R.} and L. Drago and A. Lombardi and Fassina, {M. C.} and B. Mombelli",
year = "1998",
language = "English",
volume = "10",
pages = "225--230",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - Interference on Helicobacter pylori growth and adhesion by omeprazole and other drugs

AU - Gismondo, M. R.

AU - Drago, L.

AU - Lombardi, A.

AU - Fassina, M. C.

AU - Mombelli, B.

PY - 1998

Y1 - 1998

N2 - Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal diseases. Gastroduodenal ulcer and Malt-lymphoma in particular, regress when patients are administered antimicrobial agents to eradicate infection. Somtimes eradication is not definitive and is difficult to check. The aim of our study was to test the antimicrobial activity of omeprazole on H. pylori in comparison with ampicillin and other anti-H2 drugs (ranitidine and famotidine), and to evaluate their interference with bacterial adhesion of H. pylori. We also compared results of the agar dilution antibacterial sensitivity test on H. pylori to those obtained using a bacteria adherence to cell monolayers model, to see if drug activity was different against adhered bacteria. We evaluated omeprazole and ampicillin MIC90s (minimum inhibitory concentrations) against 20 H. pylori isolates by traditional agar dilution method and by exposing previously adhered bacteria to an Hep-2 monolayer to different drug concentrations. The activity against bacteria adhered to cell lines was evaluated by counting viable adhered bacteria after 1, 6, 12 hours of contact with drug. Interference with adherence to Hep-2 cells was also tested. Omeprazole and arnpicillin MICs were comparable to other findings (omeprazole M1C90 was 12.5 μg/ml and ampicillin MIC90 was 0.016 μg/ml), while higher concentrations were necessary (4 x MIC90) against adhered bacteria. These findings suggest that MICs evaluated with traditional assays can have different predictivity than tests on adhered H. pylori.

AB - Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal diseases. Gastroduodenal ulcer and Malt-lymphoma in particular, regress when patients are administered antimicrobial agents to eradicate infection. Somtimes eradication is not definitive and is difficult to check. The aim of our study was to test the antimicrobial activity of omeprazole on H. pylori in comparison with ampicillin and other anti-H2 drugs (ranitidine and famotidine), and to evaluate their interference with bacterial adhesion of H. pylori. We also compared results of the agar dilution antibacterial sensitivity test on H. pylori to those obtained using a bacteria adherence to cell monolayers model, to see if drug activity was different against adhered bacteria. We evaluated omeprazole and ampicillin MIC90s (minimum inhibitory concentrations) against 20 H. pylori isolates by traditional agar dilution method and by exposing previously adhered bacteria to an Hep-2 monolayer to different drug concentrations. The activity against bacteria adhered to cell lines was evaluated by counting viable adhered bacteria after 1, 6, 12 hours of contact with drug. Interference with adherence to Hep-2 cells was also tested. Omeprazole and arnpicillin MICs were comparable to other findings (omeprazole M1C90 was 12.5 μg/ml and ampicillin MIC90 was 0.016 μg/ml), while higher concentrations were necessary (4 x MIC90) against adhered bacteria. These findings suggest that MICs evaluated with traditional assays can have different predictivity than tests on adhered H. pylori.

KW - Adhesion

KW - Ampicillin

KW - Antibacterial activity

KW - Antisecretory drug

KW - Gastritis

KW - Helicobacter pylori

KW - Omeprazole

KW - Ulcer

UR - http://www.scopus.com/inward/record.url?scp=0031840771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031840771&partnerID=8YFLogxK

M3 - Article

C2 - 9669648

AN - SCOPUS:0031840771

VL - 10

SP - 225

EP - 230

JO - Journal of Chemotherapy

JF - Journal of Chemotherapy

SN - 1120-009X

IS - 3

ER -